Translational Research
Volume 156, Issue 4 , Pages 235-241 , October 2010

Gene variation of the transient receptor potential cation channel, subfamily M, members 6 (TRPM6) and 7 (TRPM7), and type 2 diabetes mellitus: a case-control study

  • José R. Romero

      Affiliations

    • Division of Endocrinology, Diabetes and Hypertension, Brigham and Women’s Hospital, Harvard Medical School, Boston, Mass
    • ,
  • Amy J. Castonguay

      Affiliations

    • Division of Preventive Medicine, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, Mass
    • ,
  • Nathaniel S. Barton

      Affiliations

    • Division of Preventive Medicine, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, Mass
    • ,
  • Soren Germer

      Affiliations

    • Translational Research Sciences, Hoffmann-La Roche, Nutley, NJ
    • ,
  • Mitchell Martin

      Affiliations

    • Translational Research Sciences, Hoffmann-La Roche, Nutley, NJ
    • ,
  • Robert Y.L. Zee

      Affiliations

    • Division of Preventive Medicine, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, Mass
    • Corresponding Author InformationReprint requests: Dr. Robert Y.L. Zee, MD, Brigham and Women’s Hospital, Preventive Medicine, Harvard Medical School, 900 Commonwealth Avenue East, Boston, MA 02215

Received 11 May 2010 ,Revised 29 June 2010 ,Accepted 7 July 2010.

References 

  1. Barbagallo M, Dominguez LJ, Galioto A, et al. Role of magnesium in insulin action, diabetes and cardio-metabolic syndrome X. Mol Aspects Med. 2003;24:39–52
  2. Guerrero-Romero F, Rascon-Pacheco RA, Rodriguez-Moran M, de la Pena JE, Wacher N. Hypomagnesaemia and risk for metabolic glucose disorders: a 10-year follow-up study. Eur J Clin Invest. 2008;38:389–396
  3. Guerrero-Romero F, Rodriguez-Moran M. Low serum magnesium levels and metabolic syndrome. Acta Diabetol. 2002;39:209–213
  4. Kao WH, Folsom AR, Nieto FJ, Mo JP, Watson RL, Brancati FL. Serum and dietary magnesium and the risk for type 2 diabetes mellitus: the Atherosclerosis Risk in Communities Study. Arch Intern Med. 1999;159:2151–2159
  5. Paolisso G, Scheen A, D’Onofrio F, Lefebvre P. Magnesium and glucose homeostasis. Diabetologia. 1990;33:511–514
  6. Randell EW, Mathews M, Gadag V, Zhang H, Sun G. Relationship between serum magnesium values, lipids and anthropometric risk factors. Atherosclerosis. 2008;196:413–419
  7. Corica F, Allegra A, Ientile R, et al. Changes in plasma, erythrocyte, and platelet magnesium levels in normotensive and hypertensive obese subjects during oral glucose tolerance test. Am J Hypertens. 1999;12:128–136
  8. Guerrero-Romero F, Rodriguez-Moran M. Relationship between serum magnesium levels and C-reactive protein concentration, in non-diabetic, non-hypertensive obese subjects. Int J Obes Relat Metab Disord. 2002;26:469–474
  9. Resnick LM, Gupta RK, Gruenspan H, Alderman MH, Laragh JH. Hypertension and peripheral insulin resistance. Possible mediating role of intracellular free magnesium. Am J Hypertens. 1990;3:373–379
  10. Rosolova H, Mayer O, Reaven GM. Insulin-mediated glucose disposal is decreased in normal subjects with relatively low plasma magnesium concentrations. Metabolism. 2000;49:418–420
  11. Nadler JL, Buchanan T, Natarajan R, Antonipillai I, Bergman R, Rude R. Magnesium deficiency produces insulin resistance and increased thromboxane synthesis. Hypertension. 1993;21:1024–1029
  12. Sowers JR, Draznin B. Insulin, cation metabolism and insulin resistance. J Basic Clin Physiol Pharmacol. 1998;9:223–233
  13. Lopez-Ridaura R, Willett WC, Rimm EB, et al. Magnesium intake and risk of type 2 diabetes in men and women. Diabetes Care. 2004;27:134–140
  14. Rodriguez-Moran M, Guerrero-Romero F. Oral magnesium supplementation improves insulin sensitivity and metabolic control in type 2 diabetic subjects: a randomized double-blind controlled trial. Diabetes Care. 2003;26:1147–1152
  15. Song Y, Ridker PM, Manson JE, Cook NR, Buring JE, Liu S. Magnesium intake, C-reactive protein, and the prevalence of metabolic syndrome in middle-aged and older U.S. women. Diabetes Care. 2005;28:1438–1444
  16. Barbagallo M, Gupta RK, Resnick LM. Cellular ionic effects of insulin in normal human erythrocytes: a nuclear magnetic resonance study. Diabetologia. 1993;36:146–149
  17. Dai LJ, Ritchie G, Bapty BW, Kerstan D, Quamme GA. Insulin stimulates Mg2+ uptake in mouse distal convoluted tubule cells. Am J Physiol. 1999;277:F907–F913
  18. Ferreira A, Rivera A, Romero JR. Na+/Mg2+ exchange is functionally coupled to the insulin receptor. J Cell Physiol. 2004;199:434–440
  19. Hua H, Gonzales J, Rude RK. Magnesium transport induced ex vivo by a pharmacological dose of insulin is impaired in non-insulin-dependent diabetes mellitus. Magnes Res. 1995;8:359–366
  20. Hwang DL, Yen CF, Nadler JL. Insulin increases intracellular magnesium transport in human platelets. J Clin Endocrinol Metab. 1993;76:549–553
  21. Lostroh AJ, Krahl ME. Insulin action. Accumulation in vitro of Mg 2 + and K + in rat uterus: ion pump activity. Biochim Biophys Acta. 1973;291:260–268
  22. Paolisso G, Sgambato S, Passariello N, et al. Insulin induces opposite changes in plasma and erythrocyte magnesium concentrations in normal man. Diabetologia. 1986;29:644–647
  23. Monteilh-Zoller MK, Hermosura MC, Nadler MJ, Scharenberg AM, Penner R, Fleig A. TRPM7 provides an ion channel mechanism for cellular entry of trace metal ions. J Gen Physiol. 2003;121:49–60
  24. Schlingmann KP, Weber S, Peters M, et al. Hypomagnesemia with secondary hypocalcemia is caused by mutations in TRPM6, a new member of the TRPM gene family. Nat Genet. 2002;31:166–170
  25. Schmitz C, Deason F, Perraud AL. Molecular components of vertebrate Mg2+-homeostasis regulation. Magnes Res. 2007;20:6–18
  26. Schmitz C, Perraud AL, Johnson CO, et al. Regulation of vertebrate cellular Mg2+ homeostasis by TRPM7. Cell. 2003;114:191–200
  27. Touyz RM. Transient receptor potential melastatin 6 and 7 channels, magnesium transport, and vascular biology: implications in hypertension. Am J Physiol Heart Circ Physiol. 2008;294:H1103–H1118
  28. van der Wijst J, Hoenderop JG, Bindels RJ. Epithelial Mg2+ channel TRPM6: insight into the molecular regulation. Magnes Res. 2009;22:127–132
  29. Walder RY, Landau D, Meyer P, et al. Mutation of TRPM6 causes familial hypomagnesemia with secondary hypocalcemia. Nat Genet. 2002;31:171–174
  30. Aarts MM, Tymianski M. TRPM7 and ischemic CNS injury. Neuroscientist. 2005;11:116–123
  31. MacDonald JF, Xiong ZG, Jackson MF. Paradox of Ca2+ signaling, cell death and stroke. Trends Neurosci. 2006;29:75–81
  32. Zhao L, Shi J, Sun N, et al. Effect of electroacupuncture on TRPM7 mRNA expression after cerebral ischemia/reperfusion in rats via TrkA pathway. J Huazhong Univ Sci Technolog Med Sci. 2005;25:247–250
  33. Sontia B, Montezano AC, Paravicini T, Tabet F, Touyz RM. Downregulation of renal TRPM7 and increased inflammation and fibrosis in aldosterone-infused mice: effects of magnesium. Hypertension. 2008;51:915–921
  34. Jee SH, Miller ER, Guallar E, Singh VK, Appel LJ, Klag MJ. The effect of magnesium supplementation on blood pressure: a meta-analysis of randomized clinical trials. Am J Hypertens. 2002;15:691–696
  35. Ma J, Folsom AR, Melnick SL, et al. Associations of serum and dietary magnesium with cardiovascular disease, hypertension, diabetes, insulin, and carotid arterial wall thickness: the ARIC study. Atherosclerosis Risk in Communities Study. J Clin Epidemiol. 1995;48:927–940
  36. Chubanov V, Waldegger S, Mederos Y, et al. Disruption of TRPM6/TRPM7 complex formation by a mutation in the TRPM6 gene causes hypomagnesemia with secondary hypocalcemia. Proc Natl Acad Sci U S A. 2004;101:2894–2899
  37. Zee RY, Germer S, Thomas A, et al. C-reactive protein gene variation and type 2 diabetes mellitus: a case-control study. Atherosclerosis. 2008;197:931–936
  38. Wang J, Chuang K, Ahluwalia M, et al. High-throughput SNP genotyping by single-tube PCR with Tm-shift primers. Biotechniques. 2005;39:885–893
  39. Rinaldo A, Bacanu SA, Devlin B, Sonpar V, Wasserman L, Roeder K. Characterization of multilocus linkage disequilibrium. Genet Epidemiol. 2005;28:193–206
  40. Wallenstein S, Hodge SE, Weston A. Logistic regression model for analyzing extended haplotype data. Genet Epidemiol. 1998;15:173–181
  41. Hahn LW, Ritchie MD, Moore JH. Multifactor dimensionality reduction software for detecting gene-gene and gene-environment interactions. Bioinformatics. 2003;19:376–382
  42. Ritchie MD, Hahn LW, Moore JH. Power of multifactor dimensionality reduction for detecting gene-gene interactions in the presence of genotyping error, missing data, phenocopy, and genetic heterogeneity. Genet Epidemiol. 2003;24:150–157
  43. Song Y, Hsu YH, Niu T, Manson JE, Buring JE, Liu S. Common genetic variants of the ion channel transient receptor potential membrane melastatin 6 and 7 (TRPM6 and TRPM7), magnesium intake, and risk of type 2 diabetes in women. BMC Med Genet. 2009;10:4

 Supported by F. Hoffmann La-Roche and the National Heart, Lung and Blood Institute/NIH (RO1-HL096518).

 Conflict-of-interest disclosure: Soren Germer and Mitchell Martin are employees of F. Hoffmann La-Roche.

PII: S1931-5244(10)00149-0

doi: 10.1016/j.trsl.2010.07.001

Translational Research
Volume 156, Issue 4 , Pages 235-241 , October 2010

Article Tools